Literature DB >> 28523296

A systematic review of the possible carcinogenic role of the aristolochic acid.

Tivadar Bara1, Simona Gurzu, Haruhiko Sugimura, Tivadar Bara1, Marius Alexandru Beleaua, Ioan Jung.   

Abstract

Aristolochic acid (AA) is a bioactive component of Chinese herbs, dietary supplements, slimming pills and contaminated flour, which is known to induce chronic tubulointerstitial disease. AA is also shown to be involved in the genesis of the upper urinary tract urothelial carcinoma (UTUC) and some other cancers, but its tumorigenic role is far to be understood. We performed a systematic literature review regarding the involvement of AA in malignant processes and molecular pathways of carcinogenesis. Twenty representative papers were selected for this review. These papers reveal that AA exposure increases the risk for UTUC, renal cell carcinoma, hepatocellular carcinoma, gastric and small intestine cancer. The role of AA in lymphomagenesis is also proposed. The A:T to T:A transversions occurring in the 5'-CpApG-3' trinucleotide context of the TP53 gene is considered to be the signature mutation of AA. Genes including H-ras, FGFR3, N-ras and BRCA2 are also involved. For further understanding of AA's role in tumorigenesis, the exploration of the AA's molecular signature is necessary.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28523296

Source DB:  PubMed          Journal:  Rom J Morphol Embryol        ISSN: 1220-0522            Impact factor:   1.033


  12 in total

1.  Prevalence, clinicopathological features, and prognosis in upper tract urinary carcinoma patients with severe preoperative chronic kidney disease.

Authors:  Zhengqing Bao; Yicong Du; Yiming Yuan; Yuze Zhu; Cheng Qian; Yonghao Zhan; Dong Fang; Gengyan Xiong; Lei Zhang; Xuesong Li; Liqun Zhou
Journal:  Transl Androl Urol       Date:  2019-12

2.  Clinicopathologic characteristics and prognosis of upper tract urothelial carcinoma complicated with aristolochic acid nephropathy after radical nephroureterectomy.

Authors:  Hongli Shan; Wen Tian; Yazhao Hong; Bo Xu; Chunxi Wang; Bing Yu; Xiaoqing Wang
Journal:  BMC Complement Med Ther       Date:  2020-06-03

3.  Chinese Herbal Medicine Improves the Long-Term Survival Rate of Patients With Chronic Kidney Disease in Taiwan: A Nationwide Retrospective Population-Based Cohort Study.

Authors:  Kuo-Chin Huang; Yuan-Chih Su; Mao-Feng Sun; Sheng-Teng Huang
Journal:  Front Pharmacol       Date:  2018-10-01       Impact factor: 5.810

4.  Exposure to aristolochic acid I compromises the maturational competency of porcine oocytes via oxidative stress-induced DNA damage.

Authors:  Yu Zhang; Xiayan ShiYang; Yuwei Zhang; Yu Li; Xiaoyan Shi; Bo Xiong
Journal:  Aging (Albany NY)       Date:  2019-04-19       Impact factor: 5.682

5.  New Users of Herbal Medicine Containing Aristolochic Acids and the Risk of Dementia in the Elderly: A Nationwide, Population-Based Study in Taiwan.

Authors:  Wu-Chien Chien; Pei-Kwei Tsay; Nian-Sheng Tzeng; Yueh-Er Chiou; Chi-Hsiang Chung; Hsin-An Chang; Yu-Chen Kao
Journal:  Neuropsychiatr Dis Treat       Date:  2020-06-12       Impact factor: 2.570

6.  The Impact of p53 on Aristolochic Acid I-Induced Gene Expression In Vivo.

Authors:  Mateja Sborchia; Hector C Keun; David H Phillips; Volker M Arlt
Journal:  Int J Mol Sci       Date:  2019-12-06       Impact factor: 5.923

7.  Integrative microRNA and mRNA expression profiling in acute aristolochic acid nephropathy in mice.

Authors:  Ziqiang Zhu; Xinxing Xu; Fengying Wang; Yongrui Song; Yanping Zhu; Wei Quan; Xueli Zhang; Cheng Bi; Hongxin He; Shuang Li; Xiaozhong Li
Journal:  Mol Med Rep       Date:  2020-08-19       Impact factor: 2.952

8.  Aristolochic acid-associated urinary tract cancers: an updated meta-analysis of risk and oncologic outcomes after surgery and systematic review of molecular alterations observed in human studies.

Authors:  Yu-Chan Kang; Ming-Hong Chen; Chung-Ying Lin; Chih-Yun Lin; Yen-Ta Chen
Journal:  Ther Adv Drug Saf       Date:  2021-03-21

9.  Aristolochic acid I promoted clonal expansion but did not induce hepatocellular carcinoma in adult rats.

Authors:  Yong-Zhen Liu; Heng-Lei Lu; Xin-Ming Qi; Guo-Zhen Xing; Xin Wang; Pan Yu; Lu Liu; Fang-Fang Yang; Xiao-Lan Ding; Ze-An Zhang; Zhong-Ping Deng; Li-Kun Gong; Jin Ren
Journal:  Acta Pharmacol Sin       Date:  2021-03-08       Impact factor: 7.169

10.  Interaction between cadherins, vimentin, and V-set and immunoglobulin domain containing 1 in gastric-type hepatocellular carcinoma.

Authors:  Simona Gurzu; Janos Szederjesi; Haruhiko Sugimura; Rita Szodorai; Cornelia Braicu; Laszlo Kobori; Decebal Fodor; Ioan Jung
Journal:  Histochem Cell Biol       Date:  2021-06-25       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.